Online Desk :
India on Wednesday logged the highest-ever count of 4,205 deaths in the past 24 hours, raising the death toll to 2,54,197.
The total caseload in the country mounted to 2,33,40,938 – the second-highest after the United States- with 3,48,421 new infections, while the recoveries have surged to 1,93,82,642, according to the Union Health Ministry data updated at 8:00 am on Wednesday.
This is the third day in a row that India has recorded less than four lakh cases. A total of 19,83,804 tests were conducted in the previous day.
Meanwhile, Bharat Biotech’s COVID-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase-2 and phase-3 clinical trials on those aged between two to 18 years, official sources said.
The trial will take place in 525 subjects at various sites, including AIIMS, Delhi, AIIMS, Patna and Meditrina Institute of Medical Sciences, Nagpur.
The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organization (CDSCO) on Tuesday deliberated upon Hyderabad-based Bharat Biotech’s application, seeking permission to conduct phase II/III clinical trials to evaluate the safety, reactogenicity and immunogenicity of Covaxin jabs in children aged 2 to 18 years.
